The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC
| Autor: | Aguiar, P.N., Jr, Perry, L.A., Penny-Dimri, J., Babiker, H., Tadokoro, H., de Mello, R.A., Lopes, G.L., Jr |
|---|---|
| Zdroj: | In Annals of Oncology April 2018 29(4):1078-1078 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|